Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1562 of 6351
-
New drug aims to slow kidney damage in rare disease
Disease control Recruiting nowThe primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein creatinine ratio (UPCR).
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New radiation approach aims to safely treat Hard-to-Reach lung tumors
Disease control Recruiting nowThe objective of this study is to enhance the safety profile of SAbR in ultra-central tumors of the lung (primary or metastatic) without compromising its effectiveness.
Early phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Personalized diet after stroke may save lives, large trial tests
Disease control Recruiting nowThis study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke. In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of s…
Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
AI-Powered portable MRI could bring epilepsy diagnosis to millions who lack access
Diagnosis OngoingThe global burden of epilepsy is high affecting over 50 million people worldwide. Majority live in low- and middleincome countries (LMICs) where access to diagnosis and treatment is limited. Accurate diagnosis of epilepsy and identification of the underlying cause through brain i…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New hope for rare stomach cancer: drug cocktail shows promise in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if treatment modality including albumin-bound paclitaxel, oxaliplatin, tegafur,gimeracil and oteracil porassium capsules (SOX) and sintilimab works to treat locally advanced HER2-negative hepatoid adenocarcinoma of stomach. It will also…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Bionic ear for balance? new implant aims to steady wobbly patients
Disease control Recruiting nowThe main aim of this study is to understand if an experimental vestibular implant system can improve balance performance. The system consists of a vestibular implant combined with a cochlear implant sound processor and programming software. The implant is designed to preserve hea…
Sponsor: Cochlear • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immunotherapy drug aims to keep adrenocortical cancer at bay
Disease control Recruiting nowThis clinical trial is a single-arm, non-randomized, prospective phase II study. The study aims to evaluate if the maintenance immunotherapy with cemiplimab in patients with AdrenoCortical Carcinoma (ACC), who obtained disease response or stabilization after first-line chemother…
Phase 2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could ultrasound replace radioactive dye for cancer staging?
Diagnosis Recruiting nowThis is a prospective single-center interventional non-inferiority study where subjects are participating for one day for patients 18 years or older with melanoma, breast cancer or head \& neck cancer (including melanoma of head and neck area) and scheduled for a surgical SN proc…
Phase 2/3 • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Spinal stimulation and special air may help spinal injury patients breathe easier
Disease control Recruiting nowSpinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even…
Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI could revolutionize severe pneumonia diagnosis
Knowledge-focused OngoingSevere pneumonia (SP) is a critical illness characterized by complex etiology, rapid progression, and high mortality. Its precision diagnosis and treatment face two core challenges. First, traditional etiological diagnostic methods (such as culture, serology, PCR) suffer from low…
Sponsor: Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Real-World data shows mepolizumab may keep rare vasculitis in check Long-Term
Disease control CompletedThis observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults with eosinophilic granulomatosis with polyangiitis (EGPA) in the European real-life setting. The main questions it aims to answer are: * How effective is mep…
Sponsor: European EGPA Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New eye drops aim to soothe Sjögren's dry eye
Symptom relief Recruiting nowrhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in subjects with Sjögren's related Dry Eye Disease.
Phase 2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a 14-Minute video curb suicidal thoughts? new study tests 'Papageno' approach
Symptom relief CompletedThe purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide.
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a stronger flu shot protect lung transplant patients better?
Disease control Recruiting nowThis will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced …
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
AI guides Surgeons' knives in landmark safety trial
Symptom relief Recruiting nowToday, the majority of gallbladder removals surgeries are done using minimally invasive techniques through small cuts to help patients recover faster. However, these procedures are technically more challenging because surgeons have a restricted view of the patient's anatomy, whic…
Phase 3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Psychedelic combo trial aims to ease PTSD in veterans
Symptom relief Recruiting nowThe purpose of this study is to assess the safety and effectiveness of co-administered MDMA and psilocybin in military Veterans with a diagnosis of Posttraumatic Stress Disorder (PTSD). To apply or learn more, please view our website: https://hopkinspsychedelic.org/pamvet
Phase 1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
HIV prevention on wheels: PrEP pills offered on mobile van for drug users
Prevention CompletedFor this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Phase 4 • Sponsor: Duke University • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New combo tackles liver cancer when standard treatment stops working
Disease control Recruiting nowAtezolizumab plus bevacizumab is the first-line treatment for advanced hepatocellular carcinoma (HCC). However, the effect of the second-line treatment after the progress of Atezolizumab plus bevacizumab therapy remains unsatisfactory. This is a prospective trial to investigate t…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug aims to tame COPD Flare-Ups in Hard-to-Treat patients
Disease control Recruiting nowThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pul…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug avelumab aims to keep upper tract cancer at bay after chemo
Disease control Recruiting nowA Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Phase 2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC